Pharmaceutical composition with function of treating cerebrovascular diseases

A composition and drug technology, applied in the field of medicine, can solve the problems of many adverse reactions, limited clinical use, high price and the like
CN102697776BActive Publication Date: 2014-07-23HAINAN BIKAI PHARM CO LTD
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
HAINAN BIKAI PHARM CO LTD
Publication Date
2014-07-23

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention belongs to the technical field of medicine and particularly relates to a pharmaceutical composition with function of treating cerebrovascular diseases. The pharmaceutical composition contains ozagrel sodium and 1, 3-diaza-2, 4-cyclopentadiene, wherein the weight percentage of the ozagrel sodium is more than or equal to 95 percent and less than 100 percent, and the weight percentage of the 1, 3-diaza-2, 4-cyclopentadiene is more than zero and less than or equal to 5 percent. The pharmaceutical composition provided by the invention is determined by pharmacology experiment and toxicology experiment.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition containing ozagrel sodium. Background technique

[0002] A thrombus is a small piece of blood that forms on the surface of a vessel in the cardiovascular system where the lining has been peeled off or repaired. In variable flow dependent patterns, thrombus consists of insoluble fibrin, deposited platelets, accumulated leukocytes, and trapped red blood cells, and thrombosis is a process involving many genetic and environmental factors interacting with each other The process of multifactorial changes, clinically common patients with thrombosis diathesis, the most important features are family history, recurrent, young, severity of attack symptoms, and unusual site of thrombosis. Arterial or venous thrombosis or thromboembolism requires objective evidence. Angiography is the reference standard for diagnosis. Ultrasound detection with skillf...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More